902 KAR 55:030. Schedule IV substances.

 

      RELATES TO: KRS 218A.010-218A.030, 218A.100, 218A.110, 21 C.F.R. 1308.14, 21 U.S.C. 801, 812

      STATUTORY AUTHORITY: KRS 218A.020

      NECESSITY, FUNCTION, AND CONFORMITY: KRS 218A.020(1) authorizes the Cabinet for Health and Family Services to promulgate administrative regulations to add, delete, or reschedule substance enumerated in KRS Chapter 218A. KRS 218A.020(3) authorizes the Cabinet for Health and Family Services to promulgate administrative regulations to control substances controlled under federal law. This administrative regulation designates Schedule IV controlled substances. This administrative regulation differs from the federal regulation because it designates the following substances as a Schedule IV controlled substance: Tramadol, Carisoprodol, and Nalbuphine. The Cabinet for Health and Family Services recognizes that Tramadol, Carisoprodol, and Nalbuphine have significant abuse potential and inclusion on Kentucky's Schedule IV list will help reduce the risk to public health.

 

      Section 1. Stimulants. The Cabinet for Health and Family Services designates as Schedule IV controlled substances, in addition to those specified by KRS 218A.110, a material, compound, mixture, or preparation which contains a quantity of the following substances, including their salts, isomers whether optical, position, or geometric, and salts of the isomers, if the existence of the salts, isomers, and salts of isomers is possible:

      (1) Cathine ((+)-norpseudoephedrine);

      (2) Diethylpropion;

      (3) Fencamfamin;

      (4) Fenproporex;

      (5) Mazindol;

      (6) Mefenorex;

      (7) Modafinil;

      (8) Pemoline, including organometallic complexes and chelates;

      (9) Phentermine;

      (10) Pipradrol;

      (11) Sibutramine; and

      (12) SPA ((-)-1-dimethylamino-1,2-diphenylethane).

 

      Section 2. Depressants. The Cabinet for Health and Family Services designates as Schedule IV controlled substances, in addition to those specified by KRS 218A.110, a material, compound, mixture, or preparation which contains a quantity of the following substances, including its salts, isomers, and salts of isomers if the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation:

      (1) Alprazolam;

      (2) Bromazepam;

      (3) Camazepam;

      (4) Carisoprodol;

      (5) Chlordiazepoxide;

      (6) Clobazam;

      (7) Clonazepam;

      (8) Clorazepate;

      (9) Clotiazepam;

      (10) Cloxazolam;

      (11) Delorazepam;

      (12) Diazepam;

      (13) Dichloralphenazone;

      (14) Estazolam;

      (15) Ethyl loflazepate;

      (16) Fludiazepam;

      (17) Flunitrazepam;

      (18) Flurazepam;

      (19) Halazepam;

      (20) Haloxazolam;

      (21) Ketazolam;

      (22) Loprazolam;

      (23) Lorazepam;

      (24) Lormetazepam;

      (25) Mebutamate;

      (26) Medazepam;

      (27) Methohexital;

      (28) Midazolam;

      (29) Nimetazepam;

      (30) Nitrazepam;

      (31) Nordiazepam;

      (32) Oxazepam;

      (33) Oxazolam;

      (34) Pinazepam;

      (35) Prazepam;

      (36) Quazepam;

      (37) Temazepam;

      (38) Tetrazepam;

      (39) Triazolam;

      (40) Zaleplon;

      (41) Zolpidem; and

      (42) Zopiclone.

 

      Section 3. Fenfluamine. The Cabinet for Health and Family Services designates as Schedule IV controlled substances, in addition to those specified by KRS 218A.110, a material, compound, mixture, or preparation which contains any quantity of Fenfluramine, including its salts, isomers, whether optical, position, or geometric, and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible.

 

      Section 4. Narcotics. The Cabinet for Health and Family Services designates as Schedule IV controlled substances, in addition to those specified by KRS 218A.110, a material, compound, mixture, or preparation containing a quantity of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, as set forth below:

      (1) Butorphanol;

      (2) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane);

      (3) Not more than one (1) milligram of difenoxin and not less than twenty-five (25) micrograms of atropine sulfate per dosage unit; and

      (4) Nalbuphine.

 

      Section 5. Central Analgesics. The Cabinet for Health and Family Services designates as a Schedule IV controlled substance material, compound, mixture, or preparation which contains any quantity of Tramadol or its salts. (Recodified from 901 KAR 1:030, 4-14-82; Am. 11 Ky.R. 1678; eff. 6-4-85; 12 Ky.R. 1177; eff. 2-4-86; 13 Ky.R. 1948; eff. 6-9-87; 15 Ky.R. 866; eff. 11-4-88; 20 Ky.R. 862; 1701; eff. 2-10-94; 22 Ky.R. 1900; 2302; eff. 6-6-96; 25 Ky.R. 627; 1630; eff. 1-19-99; 26 Ky.R. 902; 1170; eff. 12-15-99; 29 Ky.R. 819; 1277; eff. 10-16-2002; 33 Ky.R. 1436; 1820; eff. 2-2-07; 34 Ky.R. 2607; 35 Ky.R. 1198; eff. 12-5-2008.)